News and Press Releases
Press releases
Theralase® Phase II NMIBC Clinical Study (Interim) Data Presented at the ASCO GU Cancer Symposium
Toronto, Ontario – February 23, 2023,Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinica...
0Theralase® Awarded TSX Venture 50 ™ Recognition as a Top Performing Company
Toronto, Ontario – February 21, 2023,Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinic...
0Theralase® Phase II NMIBC Clinical Study (Interim) Data to be Presented at the AUA Annual Meeting
Toronto, Ontario – February 2, 2023, Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinica...
0Theralase® Phase II NMIBC Clinical Study (Interim) Data to Presented at the ASCO GU Cancer Symposium
Toronto, Ontario – January 25, 2023, Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinica...
0Theralase ® Announces Warrant Extension
Toronto, Ontario – January 5, 2023, Theralase® Technologies Inc. (“Theralase” or “Company“) (TSXV:TLT)(OTCQB:TLTFF), a clinical stage ph...
0
Theralase Release’s Q322 Interim Financial Statements
Toronto, Ontario – November 29, 2022, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinica...
0Theralase® Grants Stock Options
Toronto, Ontario – November 21, 2022, Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinic...
0Theralase ® Closes Private Placement Equity Financing
Toronto, Ontario – November 17, 2022, Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinic...
0Theralase ® Commences $CAN 2.5 M Follow-On Private Placement Equity Financing
Not for distribution to U.S. news wire services or dissemination in the United States. Toronto, Ontario – October 3, 2022, Theralase® Technologi...
0Theralase ® Announces Warrant Extension
Toronto, Ontario – September 29, 2022, Theralase® Technologies Inc. (“Theralase” or “Company“) (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
0in the news
Let's Stay in Touch
Sign up to our newsletter to stay informed on news and updates from Theralase Technologies Inc.
